Mohammed Shahait (@mshahait) 's Twitter Profile
Mohammed Shahait

@mshahait

Urologist, prostate cancer, and Robotic surgery.Views are my own

ID: 820658112206147584

calendar_today15-01-2017 15:45:15

378 Tweet

415 Followers

605 Following

UroToday.com (@urotoday) 's Twitter Profile Photo

🚨 Device Failures in Minimally Invasive Surgery 🚨 This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). Key findings: 64.7% of failures due to device breakage 🛠️ 24.1% had no identified cause, raising safety concerns ⚠️ 9

🚨 Device Failures in Minimally Invasive Surgery 🚨
This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). 

Key findings:
64.7% of failures due to device breakage 🛠️
24.1% had no identified cause, raising safety concerns ⚠️
9
Société Internationale d'Urologie Journal (@siu_journal) 's Twitter Profile Photo

In this edition of #SIUJ, read the editorial on #urology practice in low- to middle-income countries. 📖Read this article: mdpi.com/3003038 📚Full Issue: mdpi.com/2563-6499/5/5 #OpenAccess #Journal SIU-Urology Peter Black Philippe spiess Lysanne Campeau, MD Thomas RW Herrmann

In this edition of #SIUJ, read the editorial on #urology practice in low- to middle-income countries. 
📖Read this article: mdpi.com/3003038
📚Full Issue: mdpi.com/2563-6499/5/5
 #OpenAccess #Journal

<a href="/SIU_urology/">SIU-Urology</a> <a href="/pcvblack/">Peter Black</a> <a href="/SpiessPhilippe/">Philippe spiess</a> <a href="/LysCampeauMD/">Lysanne Campeau, MD</a> <a href="/trwherrmann/">Thomas RW Herrmann</a>
Société Internationale d'Urologie Journal (@siu_journal) 's Twitter Profile Photo

In this original research, this study reveals disparities among #urology training programs in LMICs, emphasizing the challenges faced by LMICs in providing comprehensive education. #OpenAccess #Journal 🔗 to Full Article: mdpi.com/3000506 📰 Full Issue:

In this original research, this study reveals disparities among #urology training programs in LMICs, emphasizing the challenges faced by LMICs in providing comprehensive education.
#OpenAccess #Journal 
🔗 to Full Article: mdpi.com/3000506
📰 Full Issue:
Mohammed Shahait (@mshahait) 's Twitter Profile Photo

Our latest study, "Post-Graduate Urology Training in Low- and Middle-Income Countries", has been published in SIUJ. 🌍 This research explores the challenges and opportunities surrounding urology training programs in Low- and Middle-Income Countries (LMICs). We highlight the

UroToday.com (@urotoday) 's Twitter Profile Photo

🚨 Device Failures in Minimally Invasive Surgery 🚨 This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). Key findings: 64.7% of failures due to device breakage 🛠️ 24.1% had no identified cause, raising safety concerns ⚠️ 9

🚨 Device Failures in Minimally Invasive Surgery 🚨
This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). 

Key findings:
64.7% of failures due to device breakage 🛠️
24.1% had no identified cause, raising safety concerns ⚠️
9
Mohammed Shahait (@mshahait) 's Twitter Profile Photo

📢 New in Société Internationale d'Urologie Journal : Dr. Albala & colleagues explore the "Current Feasibility of Urologic Telesurgery in Low/Middle Income Countries." From groundbreaking tech to barriers and global equity, they examine how telesurgery could reshape care access. 🌍 #Urology #Telesurgery

Mohammed Shahait (@mshahait) 's Twitter Profile Photo

Don't miss Dr. Arthur Burnett's latest article in Société Internationale d'Urologie Journal on #HumanitarianUrology in LMICs. A compelling review of global outreach efforts, challenges, and the profound impact on both local communities and visiting aid workers. #GlobalHealth Mohamad Allaf The Johns Hopkins Brady Urological Institute

Muhammed A. Moukhtar Hammad (@mo_moukhtar) 's Twitter Profile Photo

From a chat with a legend, Dr Gamal Ghoniem, to an impactful poster attracting🌎attention SUFU ! ⭐️GLP-1RA+BOTOX in 623 OAB pts →⬇️urinary retention⬇️UTIs⬇️ antispasmodics use than❌GLP-1RA ⏳Honored to be competing for best fellow poster at my 1st #SUFU2025 UCI Urology

From a chat with a legend, Dr <a href="/ghoniem_gamal/">Gamal Ghoniem</a>, to an impactful poster attracting🌎attention <a href="/sufuorg/">SUFU</a> !

⭐️GLP-1RA+BOTOX in 623 OAB pts →⬇️urinary retention⬇️UTIs⬇️ antispasmodics use than❌GLP-1RA

⏳Honored to be competing for best fellow poster at my 1st #SUFU2025
<a href="/UCI_Urology/">UCI Urology</a>
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

Dear Colleague, Join the Prostate Cancer Care Disparity Analysis Project (ProGAP) (NCT06612034) by taking our quick 6–8 minute survey on global disparities in prostate cancer treatment. Your input is vital in shaping better care. Thank you! Link👇👇👇 qualtricsxmvcbtqb5rf.qualtrics.com/jfe/form/SV_7a…

Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

📢 Reminder! Have you taken the ProGAP survey yet? Help us uncover global disparities in prostate cancer care. Just 6–8 mins of your time can shape better, fairer treatment worldwide. 🌍 Your voice matters. 👇 Link below 👇 qualtricsxmvcbtqb5rf.qualtrics.com/jfe/form/SV_7a… OncoAlert Deborah Mukherji

BAUS (@bausurology) 's Twitter Profile Photo

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside Prostate Cancer UK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via The Times and The Sunday Times: thetimes.com/uk/healthcare/…

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ 

We, alongside <a href="/ProstateUK/">Prostate Cancer UK</a>, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer

Via <a href="/thetimes/">The Times and The Sunday Times</a>: thetimes.com/uk/healthcare/…
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

OF: Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial 📰Authors Neeraj Agarwal, MD, FASCO, Sumanta K. Pal, MD, FASCO, and colleagues thelancet.com/journals/lanon… ✏️Commentary from Deborah Mukherji, aurelius omlin thelancet.com/journals/lanon…

OF: Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial

📰Authors <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a>, <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a>,  and colleagues thelancet.com/journals/lanon…

✏️Commentary from  <a href="/dmukherji/">Deborah Mukherji</a>,  <a href="/AOmlin/">aurelius omlin</a>
thelancet.com/journals/lanon…